XML 49 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Label Element Value
Risk Return Abstract rr_RiskReturnAbstract  
Registrant Name dei_EntityRegistrantName GMO TRUST
Prospectus Date rr_ProspectusDate Jun. 30, 2024
GMO Benchmark-Free Allocation Fund  
Risk Return Abstract rr_RiskReturnAbstract  
Risk/Return [Heading] rr_RiskReturnHeading GMO BENCHMARK-FREE ALLOCATION FUND
Objective [Heading] rr_ObjectiveHeading <span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:bold;">Investment objective</span>
Objective, Primary [Text Block] rr_ObjectivePrimaryTextBlock Positive total return.
Expense [Heading] rr_ExpenseHeading <span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:bold;">Fees and expenses</span>
Expense Narrative [Text Block] rr_ExpenseNarrativeTextBlock The table below describes the fees and expenses that you may bear for each class of shares if you buy, hold, and sell shares of the Fund. You may pay other fees, such as brokerage commissions and other fees to financial intermediaries, which are not reflected in the table and example below.
Operating Expenses Caption [Text] rr_OperatingExpensesCaption <span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:bold;">Annual Fund operating expenses</span> <br/><span style="color:#000000;font-family:Times New Roman;font-size:10pt;">(expenses that you bear each year as a percentage of the value of your investment)</span>
Fee Waiver or Reimbursement over Assets, Date of Termination rr_FeeWaiverOrReimbursementOverAssetsDateOfTermination <span style="color:#000000;font-family:Times New Roman;font-size:8pt;font-style:italic;">June 30, 2025</span>
Portfolio Turnover [Heading] rr_PortfolioTurnoverHeading <span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:bold;">Portfolio turnover</span>
Portfolio Turnover [Text Block] rr_PortfolioTurnoverTextBlock The Fund pays transaction costs, such as commissions, when it buys and sells securities. A higher portfolio turnover rate may result in higher transaction costs and, for holders of Fund shares subject to U.S. taxes, higher income taxes. These transaction costs, which are not reflected in Annual Fund operating expenses or in the Example, affect the Fund’s performance. During its fiscal year ended February 29, 2024, the Fund’s portfolio turnover rate (excluding short-term investments) was 15% of the average value of its portfolio securities.
Portfolio Turnover, Rate rr_PortfolioTurnoverRate 15.00%
Expense Example [Heading] rr_ExpenseExampleHeading <span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:bold;">Example</span>
Expense Example Narrative [Text Block] rr_ExpenseExampleNarrativeTextBlock This example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The example assumes that you invest $10,000 in the Fund for the time periods indicated, regardless of whether or not you redeem your shares at the end of such periods. The example also assumes that your investment has a 5% return each year and that the Fund’s operating expenses remain the same as those shown in the table. The one year amounts shown reflect applicable expense reimbursements and waivers noted in the expense table. Although your actual costs may be higher or lower, based on these assumptions your costs would be:
Strategy [Heading] rr_StrategyHeading <span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:bold;">Principal investment strategies</span>
Strategy Narrative [Text Block] rr_StrategyNarrativeTextBlock The Fund seeks annualized returns of 5% (net of fees) above the Consumer Price Index and annualized volatility (standard deviation) of 5-10%, each over a complete market cycle. GMO does not manage the Fund to, or control the Fund’s risk relative to, any securities index or securities benchmark. The Fund is a fund of funds and invests primarily in Implementation Fund, other series of GMO Trust whether now existing or created in the future, including the Fixed Income Funds and the Alternative Funds, and in GMO-managed exchange-traded funds (collectively, the “underlying GMO Funds”) (see “Additional Information About the Funds’ Investment Strategies, Risks, and Expenses — Asset Allocation Funds”).GMO seeks to achieve the Fund’s investment objective by investing the Fund’s assets in asset classes GMO believes offer the most attractive risk-adjusted returns. GMO uses its quantitative multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of such asset classes, to determine the asset classes in which the Fund invests and how much the Fund invests in each asset class. An important component of those forecasts is GMO’s expectation that valuations ultimately revert to their fundamental fair (or intrinsic) value over a complete market cycle. GMO changes the Fund’s holdings of particular asset classes in response to changes in GMO’s investment outlook and its assessment of market valuations and may use redemptions or purchases of Fund shares to rebalance the Fund’s investments. The factors GMO considers and investment methods GMO uses can change over time.The Fund is permitted to invest in any asset class (e.g., U.S. equity, non-U.S. equity, emerging country equity, U.S. fixed income, non-U.S. fixed income, emerging country debt, and commodities), strategy (e.g., long/short and event-driven strategies), sector, country, or region, and at times may have substantial exposure to a single asset class, sector, country, region, issuer, or currency and companies with similar market capitalizations. In addition, the Fund is not restricted in its exposure to any particular market and may invest in securities of companies of any market capitalization and, in the case of debt instruments, of any credit quality (including below investment grade securities, commonly referred to as “high yield” or “junk bonds”), maturity and duration. GMO’s ability to shift investments among asset classes is not subject to any limits.The Fund typically has substantial exposure to derivatives and short-sales. Leverage is not a principal component of the Fund’s investment strategy. However, because of its derivative exposure, the Fund may at times have gross investment exposure in excess of its net assets (i.e., the Fund may be leveraged) and, therefore may be subject to higher risk of loss during those times than if the Fund were not leveraged.In seeking to achieve the Fund’s investment objective, GMO may invest a significant portion of the Fund’s net assets in cash and cash equivalents. In addition, the Fund may lend its portfolio securities. The Fund also may invest in U.S. Treasury Fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds.
Risk [Heading] rr_RiskHeading <span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:bold;">Principal risks of investing in the Fund</span>
Bar Chart and Performance Table [Heading] rr_BarChartAndPerformanceTableHeading <span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:bold;">Performance</span>
Performance Narrative [Text Block] rr_PerformanceNarrativeTextBlock The bar chart and table below provide some indication of the risks of investing in the Fund by showing changes in the Fund’s annual total returns from year to year for the periods indicated and by comparing the Fund’s average annual total returns for different calendar periods with those of the Bloomberg U.S. Treasury Inflation Notes: 1-10 Year Index and the Consumer Price Index. Share classes not shown would have substantially similar annual returns to those below because all share classes invest in the same portfolio of securities. Annual returns vary among share classes to the extent that they bear different expenses. Prior to January 1, 2012, the Fund served as a principal component of a broader GMO real return strategy that also included a pooled investment vehicle with a cash-like benchmark. Since January 1, 2012, the Fund has been managed as a standalone investment. After-tax returns are calculated using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on your tax situation and may differ from those shown. After-tax returns shown are not relevant if you are tax-exempt or if you hold your Fund shares through tax-advantaged arrangements (such as a 401(k) plan or individual retirement account). After-tax returns are shown for Class III shares only; after-tax returns for other classes will vary. Updated performance information for the Fund is available at www.gmo.com. Past performance (before and after taxes) is not an indication of future performance.
Performance Information Illustrates Variability of Returns [Text] rr_PerformanceInformationIllustratesVariabilityOfReturns <span style="color:#000000;font-family:Times New Roman;font-size:10pt;margin-left:3.76%;">The bar chart and table below provide some indication of the risks of investing in the Fund by showing changes in the Fund’s </span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;">annual total returns from year to year for the periods indicated and by comparing the Fund’s average annual total returns for different calendar periods with those of the Bloomberg U.S. Treasury Inflation Notes: 1-10 Year Index and the Consumer Price Index.</span>
Performance Availability Website Address [Text] rr_PerformanceAvailabilityWebSiteAddress <span style="color:#000000;font-family:Times New Roman;font-size:10pt;">www.gmo.com</span>
Performance Past Does Not Indicate Future [Text] rr_PerformancePastDoesNotIndicateFuture <span style="color:#000000;font-family:Times New Roman;font-size:10pt;">Past performance (before and after taxes) is not an indication of future performance.</span>
Bar Chart [Heading] rr_BarChartHeading <span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:bold;">Annual Total Returns/Class III Shares</span> <br/><span style="color:#000000;font-family:Times New Roman;font-size:10pt;">Years Ending December 31</span>
Bar Chart Closing [Text Block] rr_BarChartClosingTextBlock

Highest Quarter: 7.89% 4Q 2022
Lowest Quarter: -16.05% 1Q 2020
Year-to-Date: 3.05% As of 3/31/2024

Performance Table Heading rr_PerformanceTableHeading <span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:bold;">Average Annual Total Returns</span> <br/><span style="color:#000000;font-family:Times New Roman;font-size:10pt;">Periods Ending December 31, 2023</span>
Performance Table Uses Highest Federal Rate rr_PerformanceTableUsesHighestFederalRate <span style="color:#000000;font-family:Times New Roman;font-size:10pt;">After-tax returns are calculated using the </span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;">historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes.</span>
Performance Table Not Relevant to Tax Deferred rr_PerformanceTableNotRelevantToTaxDeferred <span style="color:#000000;font-family:Times New Roman;font-size:10pt;"> Actual after-tax </span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;">returns depend on your tax situation and may differ from those shown. After-tax returns shown are not relevant if you are tax-exempt or if you hold your Fund shares through tax-advantaged arrangements (such as a 401(k) plan or individual retirement account). </span>
Performance Table One Class of after Tax Shown [Text] rr_PerformanceTableOneClassOfAfterTaxShown <span style="color:#000000;font-family:Times New Roman;font-size:10pt;">After-tax </span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;">returns are shown for Class III shares only; after-tax returns for other classes will vary.</span>
GMO Benchmark-Free Allocation Fund | Risk Lose Money [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Many factors can affect this value, and you may lose money by investing in the Fund.
GMO Benchmark-Free Allocation Fund | Non-Diversified Funds [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock Some of the underlying funds are non-diversified investment companies under the Investment Company Act of 1940, as amended, and therefore a decline in the market price of a particular security held by those funds may affect their performance more than if they were diversified investment companies.
GMO Benchmark-Free Allocation Fund | Management and Operational Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Management and Operational Risk – The Fund runs the risk that GMO’s investment techniques will fail to produce intended results including the annualized returns and volatility the Fund is seeking to achieve. Even if the Fund achieves those returns or that volatility over a market cycle, it may experience shorter periods of significantly lower returns or higher volatility, or both. Over the three-year period and the period beginning with the inception of the Fund’s current investment strategy (July 23, 2003), in each case ending December 31, 2023, the Fund’s annualized net return (Class III shares, before taxes) less the Consumer Price Index was -1.16% and 4.35%, respectively. Over the three-year period and the period beginning July 31, 2003, in each case ending December 31, 2023, the Fund’s annualized net standard deviation (calculated using monthly net returns, before taxes) was 9.14% and 7.85%, respectively. See also “Performance” below. GMO uses quantitative models as part of its investment process. GMO’s models may not accurately predict future market movements. In addition, GMO’s models rely on assumptions and data that are subject to limitations (e.g., inaccuracies, staleness) that could adversely affect their predictive value. The Fund also runs the risk that GMO’s assessment of an investment, including a security’s fundamental fair (or intrinsic) value, is wrong or that deficiencies in GMO’s or another service provider’s internal systems or controls will cause losses for the Fund or impair Fund operations.
GMO Benchmark-Free Allocation Fund | Market Risk Equities [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Market Risk – Equities – The market price of an equity in the Fund’s portfolio may decline due to factors affecting the issuer or its industry or the economy and equity markets generally. If the Fund purchases an equity for less than its fundamental fair (or intrinsic) value as assessed by GMO, the Fund runs the risk that the market price of the equity will not appreciate or will decline, (for example, if GMO’s assessment proves to be incorrect or the market fails to recognize the equity’s intrinsic value). The Fund also may purchase equities that typically trade at higher multiples of current earnings than other securities, and the market prices of these equities often are more sensitive to changes in future earnings expectations and interest rates than the market prices of equities trading at lower multiples. Declines in stock market prices generally are likely to reduce the net asset value of the Fund’s shares.When the Fund writes put options on a stock index, the value of those options will decline when the value of that index declines. The value of an index depends on the value of the equity securities in the index. Also, the Fund’s investment strategy of writing put options on stock indices can be expected to cause that strategy to underperform relative to those indices when the value of those indices rises sharply.
GMO Benchmark-Free Allocation Fund | Non-U.S. Investment Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Non-U.S. Investment Risk – The market prices of many non-U.S. securities fluctuate more than those of U.S. securities. Many non-U.S. securities markets are less stable, smaller, less liquid, and less regulated than U.S. securities markets, and the cost of trading in those markets often is higher than in U.S. securities markets. In addition, non-U.S. securities issuers often are not subject to as much regulation as U.S. issuers, and the reporting, recordkeeping, accounting, custody, and auditing standards to which those issuers are subject often are not as rigorous as U.S. standards. In addition, the Fund is subject to taxation by countries other than the United States, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends, interest, or other amounts it realizes or accrues in respect of non-U.S. investments; (ii) transactions in those investments; and (iii) repatriation of proceeds generated from the sale or other disposition of those investments. Also, the Fund needs a license to invest directly in securities traded in many non-U.S. securities markets, and the Fund is subject to the risk that its license is terminated or suspended. In some non-U.S. securities markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Fund’s investments. The risks above (such as substantial price fluctuations and market instability, illiquidity and lack of regulation) and other risks (e.g., nationalization, expropriation or other confiscation of assets of non-U.S. issuers, difficulties enforcing legal judgments or contractual rights and geopolitical risks) tend to be higher for investments in the securities of issuers tied economically to emerging countries. The economies of emerging countries often depend predominantly on only a few industries or commodities and often are more volatile than the economies of developed countries.
GMO Benchmark-Free Allocation Fund | Market Risk Fixed Income [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Market Risk – Fixed Income – The market price of a fixed income investment can decline due to market-related factors, including rising interest or inflation rates and widening credit spreads, or decreased liquidity due, for example, to market uncertainty about the value of a fixed income investment (or class of fixed income investments).
GMO Benchmark-Free Allocation Fund | Derivatives and Short Sales Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Derivatives and Short Sales Risk – The use of derivatives involves the risk that their value may not change as expected relative to changes in the value of the underlying assets, pools of assets, rates, currencies or indices. Derivatives also present other risks, including market risk, illiquidity risk, currency risk, credit risk, leveraging risk, commodities risk and counterparty risk. The market price of an option is affected by many factors, including changes in the market prices or dividend rates of underlying securities (or in the case of indices, the securities in such indices); the time remaining before expiration; changes in interest rates or exchange rates; and changes in the actual or perceived volatility of the relevant index or underlying securities. The Fund typically creates short investment exposure by selling securities short or by taking a derivative position in which the value of the derivative moves in the opposite direction from the price of an underlying asset, pool of assets, rate, currency or index. Specifically, the net asset value of the Fund’s shares will be adversely affected if the equities or other assets that are the subject of the Fund’s short exposures appreciate in value. The risk of loss associated with derivatives that provide short investment exposure and short sales of securities is theoretically unlimited.
GMO Benchmark-Free Allocation Fund | Smaller Company Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Smaller Company Risk – Smaller companies may have limited product lines, markets, or financial resources, lack the competitive strength of larger companies, have less experienced managers or depend on a few key employees. The securities of companies with smaller market capitalizations often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
GMO Benchmark-Free Allocation Fund | Futures Contracts Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Futures Contracts Risk – The loss to the Fund resulting from its use of futures contracts is potentially unlimited. Futures markets are highly volatile, and the use of futures contracts increases the volatility of the Fund’s net asset value. A liquid secondary market may not exist for any particular futures contract at any particular time, and the Fund may be unable when it wishes to terminate its exposure under that contract. When the Fund uses futures contracts for hedging purposes, it runs the risk that changes in the prices of the contracts will not correlate perfectly with changes in the securities, index, or other asset underlying the contracts or movements in the prices of the Fund’s investments that are subject to the hedge. In addition, the Fund may be unable to recover or may be delayed in recovering margin or other amounts deposited with a futures commission merchant or futures clearinghouse. Foreign futures contracts are often less liquid and more volatile than U.S. futures contracts.
GMO Benchmark-Free Allocation Fund | Credit Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Credit Risk – The Fund runs the risk that the issuer or guarantor of a fixed income investment (including a sovereign or quasi-sovereign debt issuer) or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner or at all. The market price of a fixed income investment will normally decline as a result of the failure of an issuer, guarantor, or obligor to meet its payment obligations or in anticipation of such a failure. Below investment grade investments have speculative characteristics, and negative changes in economic conditions or other circumstances are more likely to impair the ability of issuers of those investments to make principal and interest payments than issuers of investment grade investments. In addition, investments in emerging country sovereign or quasi-sovereign debt are subject to a heightened risk that the issuer responsible for repayment of the debt may be unable or unwilling to pay interest and repay principal when due, and the Fund may lack recourse against the issuer in the event of a default. Investments in quasi-sovereign debt also are subject to the risk that the issuer will default independently of its sovereign. Investments in distressed or defaulted or other low quality debt investments generally are considered speculative and are subject to substantial risks not normally associated with investments in higher quality securities, including adverse business, financial or economic conditions that lead to their issuers’ payment defaults and insolvency proceedings. In particular, distressed or defaulted obligations might be repaid, if at all, only after lengthy workout or bankruptcy proceedings during which the issuer might not make any interest or other payments, and the Fund may incur additional expenses in its effort to be repaid. If GMO’s assessment of the eventual recovery value of a distressed or defaulted debt investment proves incorrect, the Fund may lose a substantial portion or all of its original investment or may be required to accept cash or instruments worth less than its original investment.
GMO Benchmark-Free Allocation Fund | Currency Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Currency Risk – Fluctuations in exchange rates can adversely affect the market value of the Fund’s foreign currency holdings and investments denominated in foreign currencies.
GMO Benchmark-Free Allocation Fund | Fund of Funds Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Fund of Funds Risk – The Fund is indirectly exposed to all of the risks of an investment in the underlying funds in which it invests, including the risk that those underlying funds will not perform as expected.
GMO Benchmark-Free Allocation Fund | Commodities Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Commodities Risk – Commodity prices can be extremely volatile, and exposure to commodities can cause the net asset value of the Fund’s shares to decline or fluctuate significantly in a rapid and unpredictable manner.
GMO Benchmark-Free Allocation Fund | Event-Driven Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Event-Driven Risk – If the Fund purchases securities in anticipation of a proposed merger, acquisition, exchange offer, tender offer, or other similar transaction and that transaction later appears likely to be delayed or unlikely to be consummated or, in fact, is not consummated or is delayed, the market price of the securities purchased by the Fund may decline sharply, resulting in losses to the Fund. The risk/reward payout of event-driven strategies (such as merger arbitrage) typically is asymmetric, with the losses in failed transactions often far exceeding the gains in successful transactions. Event-driven strategies are subject to the risk of overall market movements, and the Fund may experience losses even if a transaction is consummated.
GMO Benchmark-Free Allocation Fund | Illiquidity Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Illiquidity Risk – Low trading volume, lack of a market maker, large position size, or legal restrictions increase the risk that the Fund or an underlying fund is limited or prevented from selling particular securities or closing derivative positions at desirable prices at a particular time or at all.
GMO Benchmark-Free Allocation Fund | Leveraging Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Leveraging Risk – The use of derivatives, short sales and securities lending can create leverage. Leverage increases the Fund’s losses when the value of its investments (including derivatives) declines. In addition, the Fund’s portfolio will be leveraged if it exercises its right to delay payment on a redemption and the value of the Fund’s assets declines between the time a redemption request is treated as being received by the Fund and the time the Fund liquidates assets to fund that redemption.
GMO Benchmark-Free Allocation Fund | Counterparty Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Counterparty Risk – The Fund runs the risk that the counterparty to a derivatives contract or a clearing member used by the Fund to hold a cleared derivatives contract is unable or unwilling to make timely settlement payments, return the Fund’s collateral or otherwise honor its obligations.
GMO Benchmark-Free Allocation Fund | Market Disruption and Geopolitical Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Market Disruption and Geopolitical Risk – Geopolitical and other events (e.g., wars, pandemics, sanctions, terrorism) often disrupt securities markets and adversely affect the general economy or particular economies and markets. Those events, as well as other changes in non-U.S. and U.S. economic and political conditions, could exacerbate other risks or otherwise reduce the value of the Fund’s investments.
GMO Benchmark-Free Allocation Fund | Market Risk Asset Backed Securities [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Market Risk – Asset-Backed Securities – The market price of asset-backed securities, like that of other fixed income investments, can decline for a variety of reasons, including increases in interest rates. In addition, the market price can decrease due to a reduction in or decrease in the reliability of their payment streams. Payment streams associated with asset-backed securities held by the Fund depend on many factors (e.g., the cash flow generated by the assets backing the securities, deal structure, and creditworthiness of any credit-support provider), and a problem in any of these factors can lead to a reduction in the payment stream GMO expected the Fund to receive when the Fund purchased the asset-backed security. The liquidity of asset-backed securities (particularly below investment grade asset-backed securities) may change over time. During periods of deteriorating economic conditions, such as recessions, or periods of rising unemployment, delinquencies and losses generally increase, sometimes dramatically, for asset-backed securities whose underlying assets consist of loans, sales contracts, receivables and other obligations.
GMO Benchmark-Free Allocation Fund | Focused Investment Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Focused Investment Risk – Investments in countries, regions, asset classes, sectors, industries, currencies, or issuers that are subject to the same or similar risk factors and investments whose market prices are closely correlated are subject to higher overall risk than investments that are more diversified or whose market prices are not as closely correlated.
GMO Benchmark-Free Allocation Fund | Large Shareholder Risk [Member]  
Risk Return Abstract rr_RiskReturnAbstract  
Risk [Text Block] rr_RiskTextBlock ●Large Shareholder Risk – To the extent that a large number of shares of the Fund is held by a single shareholder (e.g., an institutional investor or another GMO Fund) or a group of shareholders with a common investment strategy (e.g., GMO asset allocation accounts), the Fund is subject to the risk that a redemption by that shareholder or group will require the Fund to sell investments at disadvantageous prices, disrupt the Fund’s operations, or force the Fund’s liquidation.
GMO Benchmark-Free Allocation Fund | Class III  
Risk Return Abstract rr_RiskReturnAbstract  
Management fee rr_ManagementFeesOverAssets 0.80% [1]
Other expenses rr_OtherExpensesOverAssets 0.02%
Acquired fund fees and expenses (underlying fund expenses) rr_AcquiredFundFeesAndExpensesOverAssets 0.47% [2]
Total annual fund operating expenses rr_ExpensesOverAssets 1.29%
Expense reimbursement/waiver rr_FeeWaiverOrReimbursementOverAssets (0.06%) [1]
Total annual fund operating expenses after expense reimbursement/waiver (Fund and underlying fund expenses) rr_NetExpensesOverAssets 1.23%
1 Year rr_ExpenseExampleYear01 $ 125
3 Years rr_ExpenseExampleYear03 403
5 Years rr_ExpenseExampleYear05 702
10 Years rr_ExpenseExampleYear10 $ 1,551
2014 rr_AnnualReturn2014 1.21%
2015 rr_AnnualReturn2015 (4.28%)
2016 rr_AnnualReturn2016 3.40%
2017 rr_AnnualReturn2017 13.04%
2018 rr_AnnualReturn2018 (5.35%)
2019 rr_AnnualReturn2019 11.62%
2020 rr_AnnualReturn2020 (2.49%)
2021 rr_AnnualReturn2021 2.96%
2022 rr_AnnualReturn2022 (2.26%)
2023 rr_AnnualReturn2023 13.40%
Year to Date Return, Label rr_YearToDateReturnLabel <span style="color:#000000;font-family:Times New Roman;font-size:10pt;">Year-to-Date:</span>
Bar Chart, Year to Date Return, Date rr_BarChartYearToDateReturnDate Mar. 31, 2024
Bar Chart, Year to Date Return rr_BarChartYearToDateReturn 3.05%
Highest Quarterly Return, Label rr_HighestQuarterlyReturnLabel <span style="color:#000000;font-family:Times New Roman;font-size:10pt;">Highest Quarter:</span>
Highest Quarterly Return, Date rr_BarChartHighestQuarterlyReturnDate Dec. 31, 2022
Highest Quarterly Return rr_BarChartHighestQuarterlyReturn 7.89%
Lowest Quarterly Return, Label rr_LowestQuarterlyReturnLabel <span style="color:#000000;font-family:Times New Roman;font-size:10pt;">Lowest Quarter:</span>
Lowest Quarterly Return, Date rr_BarChartLowestQuarterlyReturnDate Mar. 31, 2020
Lowest Quarterly Return rr_BarChartLowestQuarterlyReturn (16.05%)
1 Year rr_AverageAnnualReturnYear01 13.40% [3]
5 Years rr_AverageAnnualReturnYear05 4.43% [3]
10 Years rr_AverageAnnualReturnYear10 2.90% [3]
Incept. rr_AverageAnnualReturnSinceInception 6.92% [3]
Inception Date rr_AverageAnnualReturnInceptionDate Jul. 23, 2003
GMO Benchmark-Free Allocation Fund | Class IV  
Risk Return Abstract rr_RiskReturnAbstract  
Management fee rr_ManagementFeesOverAssets 0.75% [1]
Other expenses rr_OtherExpensesOverAssets 0.02%
Acquired fund fees and expenses (underlying fund expenses) rr_AcquiredFundFeesAndExpensesOverAssets 0.47% [2]
Total annual fund operating expenses rr_ExpensesOverAssets 1.24%
Expense reimbursement/waiver rr_FeeWaiverOrReimbursementOverAssets (0.06%) [1]
Total annual fund operating expenses after expense reimbursement/waiver (Fund and underlying fund expenses) rr_NetExpensesOverAssets 1.18%
1 Year rr_ExpenseExampleYear01 $ 120
3 Years rr_ExpenseExampleYear03 387
5 Years rr_ExpenseExampleYear05 675
10 Years rr_ExpenseExampleYear10 $ 1,495
1 Year rr_AverageAnnualReturnYear01 13.47%
5 Years rr_AverageAnnualReturnYear05 4.49%
10 Years rr_AverageAnnualReturnYear10 2.96%
Incept. rr_AverageAnnualReturnSinceInception 3.72%
Inception Date rr_AverageAnnualReturnInceptionDate Dec. 11, 2012
GMO Benchmark-Free Allocation Fund | Class R6  
Risk Return Abstract rr_RiskReturnAbstract  
Management fee rr_ManagementFeesOverAssets 0.80% [1]
Other expenses rr_OtherExpensesOverAssets 0.02%
Acquired fund fees and expenses (underlying fund expenses) rr_AcquiredFundFeesAndExpensesOverAssets 0.47% [2]
Total annual fund operating expenses rr_ExpensesOverAssets 1.29%
Expense reimbursement/waiver rr_FeeWaiverOrReimbursementOverAssets (0.06%) [1]
Total annual fund operating expenses after expense reimbursement/waiver (Fund and underlying fund expenses) rr_NetExpensesOverAssets 1.23%
1 Year rr_ExpenseExampleYear01 $ 125
3 Years rr_ExpenseExampleYear03 403
5 Years rr_ExpenseExampleYear05 702
10 Years rr_ExpenseExampleYear10 $ 1,551
1 Year rr_AverageAnnualReturnYear01 13.40%
5 Years rr_AverageAnnualReturnYear05
10 Years rr_AverageAnnualReturnYear10
Incept. rr_AverageAnnualReturnSinceInception 6.42%
Inception Date rr_AverageAnnualReturnInceptionDate May 01, 2020
GMO Benchmark-Free Allocation Fund | Class I  
Risk Return Abstract rr_RiskReturnAbstract  
Management fee rr_ManagementFeesOverAssets 0.80% [1]
Other expenses rr_OtherExpensesOverAssets 0.13% [4]
Acquired fund fees and expenses (underlying fund expenses) rr_AcquiredFundFeesAndExpensesOverAssets 0.47% [2]
Total annual fund operating expenses rr_ExpensesOverAssets 1.40%
Expense reimbursement/waiver rr_FeeWaiverOrReimbursementOverAssets (0.06%) [1],[4]
Total annual fund operating expenses after expense reimbursement/waiver (Fund and underlying fund expenses) rr_NetExpensesOverAssets 1.34%
1 Year rr_ExpenseExampleYear01 $ 136
3 Years rr_ExpenseExampleYear03 437
5 Years rr_ExpenseExampleYear05 760
10 Years rr_ExpenseExampleYear10 $ 1,675
1 Year rr_AverageAnnualReturnYear01 13.28%
5 Years rr_AverageAnnualReturnYear05
10 Years rr_AverageAnnualReturnYear10
Incept. rr_AverageAnnualReturnSinceInception 3.83%
Inception Date rr_AverageAnnualReturnInceptionDate Aug. 08, 2019
GMO Benchmark-Free Allocation Fund | Return After Taxes on Distributions | Class III  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 11.36% [3]
5 Years rr_AverageAnnualReturnYear05 3.40% [3]
10 Years rr_AverageAnnualReturnYear10 1.92% [3]
Incept. rr_AverageAnnualReturnSinceInception 5.39% [3]
GMO Benchmark-Free Allocation Fund | Return After Taxes on Distributions and Sale of Shares | Class III  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 8.37% [3]
5 Years rr_AverageAnnualReturnYear05 3.24% [3]
10 Years rr_AverageAnnualReturnYear10 1.99% [3]
Incept. rr_AverageAnnualReturnSinceInception 5.22% [3]
GMO Benchmark-Free Allocation Fund | Consumer Price Index (returns reflect no deduction for fees, expenses, or taxes) | Class III  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 3.60%
5 Years rr_AverageAnnualReturnYear05 4.09%
10 Years rr_AverageAnnualReturnYear10 2.79%
Incept. rr_AverageAnnualReturnSinceInception 2.57%
GMO Benchmark-Free Allocation Fund | Consumer Price Index (returns reflect no deduction for fees, expenses, or taxes) | Class IV  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 3.60%
5 Years rr_AverageAnnualReturnYear05 4.09%
10 Years rr_AverageAnnualReturnYear10 2.79%
Incept. rr_AverageAnnualReturnSinceInception 2.66%
GMO Benchmark-Free Allocation Fund | Consumer Price Index (returns reflect no deduction for fees, expenses, or taxes) | Class R6  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 3.60%
5 Years rr_AverageAnnualReturnYear05
10 Years rr_AverageAnnualReturnYear10
Incept. rr_AverageAnnualReturnSinceInception 5.26%
GMO Benchmark-Free Allocation Fund | Consumer Price Index (returns reflect no deduction for fees, expenses, or taxes) | Class I  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 3.60%
5 Years rr_AverageAnnualReturnYear05
10 Years rr_AverageAnnualReturnYear10
Incept. rr_AverageAnnualReturnSinceInception 4.34%
GMO Benchmark-Free Allocation Fund | Bloomberg U.S. Treasury Inflation Notes: 1-10 Year Index (returns reflect no deduction for fees, expenses, or taxes) | Class III  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 4.36%
5 Years rr_AverageAnnualReturnYear05 3.43%
10 Years rr_AverageAnnualReturnYear10 2.31%
Incept. rr_AverageAnnualReturnSinceInception 3.40%
GMO Benchmark-Free Allocation Fund | Bloomberg U.S. Treasury Inflation Notes: 1-10 Year Index (returns reflect no deduction for fees, expenses, or taxes) | Class IV  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 4.36%
5 Years rr_AverageAnnualReturnYear05 3.43%
10 Years rr_AverageAnnualReturnYear10 2.31%
Incept. rr_AverageAnnualReturnSinceInception 1.51%
GMO Benchmark-Free Allocation Fund | Bloomberg U.S. Treasury Inflation Notes: 1-10 Year Index (returns reflect no deduction for fees, expenses, or taxes) | Class R6  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 4.36%
5 Years rr_AverageAnnualReturnYear05
10 Years rr_AverageAnnualReturnYear10
Incept. rr_AverageAnnualReturnSinceInception 2.25%
GMO Benchmark-Free Allocation Fund | Bloomberg U.S. Treasury Inflation Notes: 1-10 Year Index (returns reflect no deduction for fees, expenses, or taxes) | Class I  
Risk Return Abstract rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 4.36%
5 Years rr_AverageAnnualReturnYear05
10 Years rr_AverageAnnualReturnYear10
Incept. rr_AverageAnnualReturnSinceInception 2.48%
[1] Includes both management fee of 0.65% and class-specific shareholder service fee, if any, for each class of shares. For additional information about the shareholder service fee applicable to each class of shares of the Fund, please see the table included in the section of the Prospectus entitled “Multiple Classes and Eligibility.” Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”) has contractually agreed to reimburse the Fund for the following expenses: audit expenses, fund accounting expenses, pricing service expenses, expenses of non-investment related tax services, transfer agency expenses (excluding, in the case of Class I shares, any amounts paid for sub-transfer agency, recordkeeping and other administrative services provided by financial intermediaries for the benefit of Class I shareholders), expenses of non-investment related legal services provided to the Fund by or at the direction of GMO, federal securities law filing expenses, printing expenses, state and federal registration fees and custody expenses. This reimbursement will continue through at least June 30, 2025 and may not be terminated prior to this date without the action or consent of the Trust’s Board of Trustees. GMO also has contractually agreed to waive or reduce, through at least June 30, 2025, the Fund’s management and shareholder service fees to the extent necessary to offset the management fees and shareholder service fees paid to GMO that are directly or indirectly borne by the Fund or a class of shares of the Fund as a result of the Fund’s direct or indirect investments in other series of GMO Trust (“GMO Funds”).
[2] Consists of approximately 0.07% in underlying fund fees and expenses, less than 0.01% in interest expense and borrowing costs for investments sold short incurred by underlying funds, 0.37% in dividend expenses on short sales incurred by underlying funds and 0.03% in purchase premiums and redemption fees paid to underlying funds. The underlying funds also receive income in connection with short sales, which is reflected in the Fund’s net income but is not reflected as an offset to dividend expenses on short sales in the Fund’s annual fund operating expenses table.
[3] The returns shown for periods prior to January 1, 2012 are for Class III shares of the Fund under the Fund’s prior fee arrangement. Under the Fund’s current fee arrangement, the returns for periods prior to January 1, 2012 would have been lower.
[4] Includes payments for sub-transfer agency, recordkeeping and other administrative services provided by financial intermediaries for the benefit of Class I shareholders. GMO has contractually agreed to waive its fees with respect to and/or reimburse Class I shares to the extent that amounts paid by the Fund out of the net assets attributable to Class I shares for sub-transfer agency, recordkeeping and other administrative services provided by financial intermediaries for the benefit of Class I shareholders exceed 0.15% of the average daily net assets attributable to Class I shares. This reimbursement will continue through at least June 30, 2025 and may not be terminated prior to this date without the action or consent of the Trust’s Board of Trustees.